علی مردان زاده, مهدی
بیمارستان شهید بهشتی، دانشگاه علوم پزشکی کرمان
[ 1 ] - مروری بر فینگولیمد؛ اولین داروی خوراکی برای مالتیپلاسکلروزیس
Multiple sclerosis (MS) is a progressive neurological autoimmune disease that usually starts in the late third and early forth decades of life. Demyelination of neurons in the central nervous system (CNS) and, subsequently, loss of nerve cells is the known disease pathogenesis. The disease is controlled by a class of medicines which are mainly immunomodulators. Fingolimod (FIN) is...
نویسندگان همکار